These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
5. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Nijenhuis S; Zendman AJ; Vossenaar ER; Pruijn GJ; vanVenrooij WJ Clin Chim Acta; 2004 Dec; 350(1-2):17-34. PubMed ID: 15530456 [TBL] [Abstract][Full Text] [Related]
7. [Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis]. Suzuki K Nihon Rinsho; 2005 Jan; 63 Suppl 1():341-3. PubMed ID: 15799374 [No Abstract] [Full Text] [Related]
8. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452 [TBL] [Abstract][Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in rheumatoid arthritis: a review. Mewar D; Wilson AG Biomed Pharmacother; 2006 Dec; 60(10):648-55. PubMed ID: 17064873 [TBL] [Abstract][Full Text] [Related]
11. Proteomic: new advances in the diagnosis of rheumatoid arthritis. Tampoia M; Brescia V; Fontana A; Maggiolini P; Zucano A; Pansini N Clin Chim Acta; 2005 Jul; 357(2):219-25. PubMed ID: 15896730 [TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455 [No Abstract] [Full Text] [Related]
14. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought. Ménard HA J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718 [No Abstract] [Full Text] [Related]
16. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies. Escalona M; López-Longo FJ; González CM; Monteagudo I; Rodríguez-Mahou M; Grau R; Carreño L J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311 [TBL] [Abstract][Full Text] [Related]
17. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401 [TBL] [Abstract][Full Text] [Related]
18. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis. Somers K; Stinissen P; Somers V Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946 [TBL] [Abstract][Full Text] [Related]
20. Mutated citrullinated vimentin antibodies in rheumatoid arthritis. Kuna AT Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]